Abstract
A novel optical biosensor technique is being developed for the early detection of myocardial infarction by utilizing the distance-dependent chemical transduction method of fluorescence resonance energy transfer (FRET). The FRET process requires two fluorophores termed the donor and the acceptor. When in close proximity, the donor absorbs energy from the excitation source and non-radiatively transfers the energy to the acceptor, which in turn emits fluorescent energy. This distance-dependent property was utilized to detect conformational changes when antibodies combine with their respective antigens. The fluorophores were conjugated to an antibody–Protein A complex and then immobilized via silanization to the distal ends of optical fibers. Three different antibody–Protein A complexes were immobilized: generic IgG, cardiac Troponin T (cTnT), and cardiac Troponin I (cTnI). Results showed that upon the addition of the specific antigens, the antibodies underwent a conformational change, reducing the distance between the FRET fluorophores. The generic IgG responded to 233 nM antigens, whereas the cTnT biosensor had a limit of detection of 75 nM, and the cTnI biosensors had a limit of detection of 94 nM.
Similar content being viewed by others
References
Mair J (1998) Tissue release of cardiac markers: from physiology to clinical applications. Clin Chem Lab Med 37:1077–1084
Vander A, Sherman J, Luciano D (2001) Human physiology: the mechanisms of body function 8th edn. McGraw-Hill, New York
Muller-Bardorff M, Freitag H, Scheffold T, Remppis A, Kubler W, Katus H (1995) Development and characterization of a rapid assay for bedside determinations of cardiac troponin T. Circulation 92:2869–2875
Wu A, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Valdes R (1999) National academy of clinical biochemistry standards of laboratory practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 45:1104–1121
CureResearch (2004) National Heart, Lung, and Blood Institute. March, 2004. Available at http://www.curereserach.com
Collinson PO (1998) Troponin T or troponin I or CK-MB (or none?). Eur Heart J 19:N16–N24
Panteghini M, Pagani F, Bonetti G (1999) The sensitivity of cardiac markers: an evidence-based approach. Clin Chem Lab Med 37:1097–1106
Hartmann F, Kampmann M, Frey N, Muller-Bardorff M, Katus HA (1998) Biochemical marker in the diagnosis of coronary artery disease. Eur Heart J 19:N2–N7
Jaffe AS, Ravkidle J, Roberts R, Naslund U, Apple FS, Galvani M, Katus H (2000) It’s time for a change to a troponin standard. Circulation 102:1216–1220
Berney C, Danuser G (2003) FRET or No FRET: a quantitative comparison. Biophys J 84:3992–4010
Lakowicz JR (1999) Principles of fluorescence spectroscopy, 2nd edn. Kluwer/Plenum, New York
Lichlyter D, Grant SA, Soykan O (2003) Development of a novel FRET immunosensor technique. Biosens Bioelectron 19:219–226
Grant SA, Pierce ME, Lichlyter DJ, Soykan O (2004) Investigation a of a FRET immunosensor technique for the detection of Troponin T and I. Sensor Lett 2:58–63
Grant SA, Lichlyter DJ (2003) Immobilization techniques for novel FRET-labeled immunosensors. SCI2003 conference proceeding, Orlando, FL, pp 27–30
Rabbany SY, Donner BL, Ligler FS (1994) Optical immunosensors. Crit Rev Biomed Eng 22:307–346
Bhatia SK, Shriver-Lake LC, Prior K, George JH, Clavert JM, Bredehorst R, Ligler FS (1989) Use of thiol-terminal silanes and heterobifucntional crosslinkers for immobilization of antibodies on silica surfaces. Anal Biochem 178:408–413
Roitt IM, Delves PJ (2001) Roitt’s essential immunology, 10th edn. Blackwell, Oxford
Acknowledgements
This work was supported, in part, by an Industrial Grant from Medtronic, Inc. (Fridley, MN), by the Missouri Agricultural Experiment Station, and the Missouri Food for the 21st Century.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Grant, S.A., Pierce, M.E., Lichlyter, D.J. et al. Effects of immobilization on a FRET immunosensor for the detection of myocardial infarction. Anal Bioanal Chem 381, 1012–1018 (2005). https://doi.org/10.1007/s00216-004-2976-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-004-2976-4